
|Articles|November 15, 2017
Medidata Selected by ICON to Evolve Image Management and Accelerate Research Goals
Advertisement
Medidata and ICON announced a new collaboration to enhance the management of medical imaging during drug development research for sponsors and sites during clinical trials. This new imaging technology will allow their customers to gain the added benefit of real time image access which will ultimately speed up clinical trials.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
3
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
4
ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files
5




